ClinicalTrials.gg
RecruitingNCT06569901Updated Nov 18, 2026

Strengthening Hope After ICU Discharge

An interventional study of Hope Intervention in Critical Care, sponsored by Oslo University Hospital. Recruiting at 4 sites in Norway. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Oslo University Hospital · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Sep 2024; still recruiting 2 years 2 months later.
Updated Nov 18, 2026Site recruiting status changedPrimary completion moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
190
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate an interventional program that aims to strengthen hope in intensive care unit (ICU) patients in the rehabilitation phase. The main questions it aims to answer are:

To develop and implement a follow-up service to strengthen hope in ICU patients, and to evaluate the effect on hope in a stepped wedge randomized trial.

To identify possible predictive factors (facilitators and barriers) associated with hope.

Participants will be asked to take part in an ICU follow-up service, a "Hope Intervention" consisting of digital individual- and group conversations. The program will address topics that are important for hope, such as active involvement, social relationships, believes and thoughts of the future.

The investigators will compare the level of hope between participants who have completed the "Hope Intervention" to those that have not yet completed the program.

Read the detailed description

The ICU patient's situation is challenging as they are acutely ill over a prolonged period of time and receive life sustaining treatment in the ICU.

Having hope and belief in a positive future, even when the prospects of such future are uncertain, may give strength and motivation and possibly improve the outcome in the rehabilitation phase. Hope is scarcely described in ICU patients.

Health care professionals need to learn how to best support ICU patients and promote hope during the rehabilitation period. Therefore, the main aim of the present study is to develop, implement and evaluate a follow up service to former ICU patients to strengthen their hope using a stepped wedge cluster randomized control intervention trial (SW-CRT). The secondary aim is to identify possible predictive factors associated with hope.

The intervention will start after hospital discharge and will be carried out in group sessions.

02

Conditions studied

  • Critical Care

Browse trials for

Keywords

  • Critical Care
  • Critical Illness
  • Critical Care Outcomes
  • Post-ICU
  • Hope
  • Intervention study
03

In context

Critical Illness

1,787 studies on the registry are indexed under Critical Illness; 445 are open to participants now.

This study's planned enrollment of 190 is above the median of 90 across 930 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Oslo University Hospital is the lead sponsor of 835 studies on the registry; 148 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients ≥18 years
  • ICU patient for > 48 hours
  • must be able to communicate verbally just after their ICU stay and be able to handle digital meetings

Exclusion criteria

Exclusion Criteria:

  • Patients with severe cognitive impairment
  • Do not understand and speak Norwegian
  • Patients with major psychiatric challenges, suicidal attempts as a reason for ICU stay
  • Age over 85 years.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
190 participants (estimated)

Study arms

  • Experimental
    Cluster A

    Cluster A will participate in the Hope Intervention shortly after randomization. Prior the intervention the participants will serve as controls.

    Behavioral: Hope Intervention

  • Experimental
    Cluster B

    Cluster B will participate in the Hope Intervention when Cluster A ends, approximately four weeks after randomization. Prior the intervention the participants will serve as controls.

    Behavioral: Hope Intervention

  • Experimental
    Cluster C

    Cluster C will participate in the Hope Intervention when Cluster B ends, approximately eight weeks after randomization. Prior the intervention the participants will serve as controls.

    Behavioral: Hope Intervention

Interventions

  • BehavioralHope Intervention

    Group meetings after hospital discharge reflecting on themes that may have an impact on hope. The Hope Intervention consists of four group meetings and two individual conversations during a four week period.

06

What researchers measure

Primary outcomes

  1. Hope

    Level of hope will be measured by Herth Hope Index (HHI). Baseline is measured after the patient has been discharged from the hospital. The HHI consists of 12 items measuring levels of hope related to cognitive and affective factors. Item scores range from 1 (strongly disagree) to 4 (strongly agree) and the total score ranges from 12 to 48. A high score indicates higher level of hope.

    Time frame: Before hospital admission, baseline and 1, 2 and 3, months after baseline

Secondary outcomes

  1. Social Provsion Scale

    Level of social support will be measured by Social Provision Scale (SPS). Baseline is measured after hospital discharge. The SPS consists of 16 assertions about social support that may apply to the individual. Item scores options are; strongly disagree, disagree, agree, and strongly agree. The total score ranges from 16-64, and a high score indicates a high level of social support.

    Time frame: Baseline and 1,2 and 3 months after baseline

  2. Charlson comorbidity Index

    Data on comorbidity will be measured with Charlson comorbidity Index (CCI) , collected from the medical record. The CCI categorize the patients' comorbidities and each comorbidity has an associated weight (from 1 to 6). The total scor ranges from 0-37, and the higher the score, the more likely the predicted outcome will result in mortality.

    Time frame: Baseline

  3. Memorial Symptom Assessment Scale

    Level of symptoms is measured by Memorial Symptom Assessment Scale (MSAS). MSAS consist of 28 predefined symptomes, were 0 indicated not having the symptom and 1 indicates having the symptom. Maximum number of predefined symptoms is 28, and indicates a worse outcome. If the respondent answers "yes" on a symptom, they are asked at what time the symptom occured, and to rate the severity and distress of the symptom using a numeric rating scale from 0 to 10. Zero indicating "not at all" and 10 "very much". A higher score indicates a worse outcome. Baseline is measured after hospital discharge.

    Time frame: Baseline and 1,2 and 3 months after baseline

  4. General Perceived Self-Efficacy Scale

    Level of a general sense of perceived self-efficacy is measured by General Perceived Self-Efficacy Scale (GSE).The short-form scale consists of items, and each item scores on a 4-point scale from 1 (not at all true) to 4 (exactly true). Total score ranges from 5-20, where high scores reflect courage and perseverance and coping both with daily hassles and stressful life events Baseline is measured after hospital discharge.

    Time frame: Baseline and 1,2 and 3 months after baseline

  5. Cognitive Failure Questionnaire

    Level of cognitive function is measured by the Cognitive Failure Questionnaire (CFQ). The questionnaire has five responses from "never" (0) to "very often" (4). A lower score indicates better cognition. Baseline is measured after hospital discharge.

    Time frame: Baseline and 1,2 and 3 months after baseline

Other outcomes

  1. Clinical Frailty Score

    Clinical Frailty Score (CFS) evaluates the patients' frailty before admission to the hospital. CFS is a nine-item scale to quantify frailty ranging from one (very fit) to nine (terminally ill) with pictographs and description of the frailty level.

    Time frame: Before hospital admission

07

Study locations

4 of 4 sites recruiting
08

References and documents

Publications

  • Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs. 1992 Oct;17(10):1251-9. doi: 10.1111/j.1365-2648.1992.tb01843.x. PubMed 1430629 ↗
  • Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003 Aug;38(4):1103-20. doi: 10.1111/1475-6773.00165. PubMed 12968819 ↗
  • Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982 Feb;21(1):1-16. doi: 10.1111/j.2044-8260.1982.tb01421.x. PubMed 7126941 ↗
  • Russell D, Cutrona CE, Rose J, Yurko K. Social and emotional loneliness: an examination of Weiss's typology of loneliness. J Pers Soc Psychol. 1984 Jun;46(6):1313-21. doi: 10.1037//0022-3514.46.6.1313. PubMed 6737214 ↗
  • Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A(9):1326-36. doi: 10.1016/0959-8049(94)90182-1. PubMed 7999421 ↗
  • Dufault K, Martocchio BC. Symposium on compassionate care and the dying experience. Hope: its spheres and dimensions. Nurs Clin North Am. 1985 Jun;20(2):379-91. PubMed 3846980 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2024 (actual). Primary completion is estimated for Dec 2026, 27 months after the start.

Of 405 non-industry interventional studies with no phase under Critical Illness, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's planned 27 months is above that.

Counting every sponsor, half of 409 studies reached it within 21 months; a quarter within 11 and three quarters within 40.

Critical Illness covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

Primary completion moved once since we started tracking on Sep 25, 2026: Dec 2025 → Dec 2026, on Nov 18, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 15, 2024
First posted
Aug 26, 2024
StartActual
Sep 10, 2024
Primary completionEst.
Dec 2026was Dec 2025
CompletionEst.
Sep 2030
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added. 2 sites changed recruiting status (2 now recruiting)
Show 2 sites
  • Vestre Viken HF, Bærum Hospital · Drammen, NorwayNot yet recruiting→Recruiting
  • Diakonhjemmet Hospital · Oslo, NorwayNot yet recruiting→Recruiting
Show site
  • St. Olavs hospital, Trondheim University Hospital · Trondheim, Norway
Nov 18, 2026
Primary completion
Dec 2025→Dec 2026
Nov 18, 2026
Enrollment
75→190
Nov 18, 2026
Interventions
Arms removed: Cluster D·Cluster E
Nov 18, 2026
Primary outcomes
1 time frame changed
What changed in the outcomes
  • Time frameHopeBaseline and 1,2,3,4 and 5 months after baseline → Before hospital admission, baseline and 1, 2 and 3, months after baseline
Nov 18, 2026
Secondary outcomes
5 time frame changed, 1 added
What changed in the outcomes
  • Time frameSocial Provsion ScaleBaseline and 1,2,3,4 and 5 months after baseline → Baseline and 1,2 and 3 months after baseline
  • Time frameCharlson comorbidity IndexWithin 2 months after inclucion → Baseline
  • Time frameMemorial Symptom Assessment ScaleBaseline and 1,2,3,4 and 5 months after baseline → Baseline and 1,2 and 3 months after baseline
  • Time frameGeneral Perceived Self-Efficacy ScaleBaseline and 1,2,3,4 and 5 months after baseline → Baseline and 1,2 and 3 months after baseline
  • Time frameCognitive Failure QuestionnaireBaseline and 1,2,3,4 and 5 months after baseline → Baseline and 1,2 and 3 months after baseline
  • Addedother outcomeClinical Frailty ScoreTime frame: Before hospital admission
Nov 18, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Vestre Viken HF, Bærum Hospital · Drammen, NorwayContact none listed→•••9017
Nov 18, 2026
Sponsor
Collaborators added: St. Olavs Hospital
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    1 site added. 2 sites changed recruiting status (2 now recruiting)
    Show 2 sites
    • Vestre Viken HF, Bærum Hospital · Drammen, NorwayNot yet recruiting→Recruiting
    • Diakonhjemmet Hospital · Oslo, NorwayNot yet recruiting→Recruiting
    Show site
    • St. Olavs hospital, Trondheim University Hospital · Trondheim, Norway
    Primary completion Dec 2025→Dec 2026
    Enrollment 75→190
    Primary outcomes 1 time frame changed
    What changed in the outcomes
    • Time frameHopeBaseline and 1,2,3,4 and 5 months after baseline → Before hospital admission, baseline and 1, 2 and 3, months after baseline
    Secondary outcomes 5 time frame changed, 1 added
    What changed in the outcomes
    • Time frameSocial Provsion ScaleBaseline and 1,2,3,4 and 5 months after baseline → Baseline and 1,2 and 3 months after baseline
    • Time frameCharlson comorbidity IndexWithin 2 months after inclucion → Baseline
    • Time frameMemorial Symptom Assessment ScaleBaseline and 1,2,3,4 and 5 months after baseline → Baseline and 1,2 and 3 months after baseline
    • Time frameGeneral Perceived Self-Efficacy ScaleBaseline and 1,2,3,4 and 5 months after baseline → Baseline and 1,2 and 3 months after baseline
    • Time frameCognitive Failure QuestionnaireBaseline and 1,2,3,4 and 5 months after baseline → Baseline and 1,2 and 3 months after baseline
    • Addedother outcomeClinical Frailty ScoreTime frame: Before hospital admission
    Interventions Arms removed: Cluster D·Cluster E
    Sponsor Collaborators added: St. Olavs Hospital
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Vestre Viken HF, Bærum Hospital · Drammen, NorwayContact none listed→•••9017
    + 3 other changes: verification date, description and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06569901
Collaborators
Vestre Viken Hospital Trust, Diakonhjemmet Hospital, St. Olavs Hospital
Responsible party
Tone Rustøen (Reseacher, Professor, Oslo University Hospital) — Principal investigator
First posted
Aug 26, 2024
Start date
Sep 10, 2024
Primary completion
Dec 2026 (estimated)
Completion
Sep 2030 (estimated)
Last update
Nov 18, 2026

Study contacts

Kristin W Sunde, Msc
Contact
krflat@ous-hf.no
+4792095804
Hanne Birgit Alfheim, PhD
Contact
halfheim@vestreviken.no
+4767509017
Tone Rustøen, PhD
principal investigator · Oslo University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion